MTVA
MetaVia
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Key Stats
--DAY`S RANGE--
--52 WK RANGE--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
About MTVA
Metavia Inc.
A biotechnology company dedicated to developing drugs for the treatment of cardiovascular metabolic diseases
545 Concord Avenue, Suite 210, Cambridge, Massachusetts 02138
--
MetaVia Inc., was incorporated in Michigan on November 10, 2008 under the name Michigan Life Therapeutics, LLC (MLT). NeuroBo Pharmaceuticals, Inc., is a clinical-stage biotechnology company focused on the development and commercialization of new drugs for the treatment of cardiometabolic diseases. NeuroBo has two main programs, focusing on the treatment of non-alcoholic steatohepatitis (NASH), obesity and type 2 diabetes (T2D).
Company Financials
EPS
MTVA has released its 2024 Q2 earnings. EPS was reported at -1.85, versus the expected -1.12, missing expectations. The chart below visualizes how MTVA has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
